Settlement reached with Purdue Pharma (Canada) for opioid damages

Opioid manufacturer Purdue Pharma (Canada) (Purdue Canada) has agreed to a first of its kind settlement in Canada resulting from B.C.-led efforts to recover health-care costs related to the sale and marketing of opioid-based pain medicines.

The settlement was reached in the context of a proposed class-action lawsuit brought by British Columbia on behalf of all Canadian governments.

Learn more here.